Validation of non-invasive central blood pressure devices: ARTERY Society task force consensus statement on protocol standardization

Affiliations

• ¹ Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
• ² Faculty of Medicine and Health Sciences, Department of Biomedical Sciences, Macquarie University, Sydney, Australia.
• ³ Clinic of Internal Medicine II, University Hospital Schleswig-Holstein, Luebeck, Germany.
• ⁴ Département de Médecine Gériatrique, CHRU de Nancy and INSERM U1116, Université de Lorraine, Vandoeuvre-les-Nancy, France.
• ⁵ Hypertension and Cardiovascular Prevention Unit, Hôtel-Dieu University Hospital, Assistance Publique-Hôpitaux de Paris, University Paris Descartes, Paris, France.
• ⁶ Departments of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, Paris, France.
• ⁷ Faculty of Medicine, Department of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.
• ⁸ Department of Clinical Pharmacology, King's College London British Heart Foundation Centre, London, UK.
• ⁹ Department of Biomedical Sciences, School of Health Sciences, Cardiff Metropolitan University, Cardiff, UK.
• ¹⁰ Cardiovascular Medicine Group, Division of Diabetes and Nutritional Sciences, King's College, London, UK.
• ¹¹ School of Public Health, The University of Queensland, Herston, Brisbane, Australia.
• ¹² Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
• ¹³ Institute of Cardiovascular Science, University College London, London, UK.
• ¹⁴ First Department of Cardiology and Hypertension, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.
• ¹⁵ Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, UK.
• ¹⁶ Pulse Wave Consulting, Saint Leu la Foret, France.
• ¹⁷ Biomedical Engineering Unit, First Department of Cardiology, Hippokration Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
• ¹⁸ Department of Cardiology, S. Luca Hospital, Istituto Auxologico Italiano, Milan, Italy.
• ¹⁹ Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
• ²⁰ Department of Medicine/Cardiology, Cheil General Hospital, Dankook University College of Medicine, Seoul, Korea.
• ²¹ Department of Pathophysiology, Cardiovascular Prevention and Research Unit, 'Laiko' Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
• ²² Division of Cardiology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
• ²³ Dipartimento di Medicina, Università di Perugia, Unità di Medicina Interna, Ospedale 'S. Maria', Terni, Italy.
• ²⁴ IBiTech-bioMMeda, Ghent University, Ghent, Belgium.
• ²⁵ Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, Third Department of Medicine, Sotiria Hospital, Athens, Greece.
• ²⁶ Department of Cardiology, Tokyo Medical University, Tokyo, Japan.
• ²⁷ Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ²⁸ Heymans Institute of Pharmacology, Ghent University, Ghent, Belgium.
• ²⁹ The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
• ³⁰ Health & Environment Department, Austrian Institute of Technology, Vienna, Austria.
• ³¹ Cardiology Department, Klinikum Wels-Grieskirchen, Wels, Austria.
• ³² First Department of Cardiology, Hippokration Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.